Ryan LeRoy

We explore two key topics using Medicare fee-for-service claims involving mild cognitive impairment or Alzheimer’s disease.

Medicaid beneficiaries with respiratory or mental health conditions who adhere to their prescribed medication regimens show fewer inpatient and emergency department visits.

We examine the impact of anti-obesity medication coverage in the Medicaid and commercial markets, as drugs such as Wegovy and Zepbound take off.